Article
16 Jan 2025
FDA Finalizes Its SIUU Guidance: An Analysis Of The Key Changes From The 2023 Draft Guidance
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
15 Jul 2024
FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs
Article
08 May 2024
Five Key Takeaways From FDA's Updated Draft Guidance On Biosimilars Promotion
Article
27 Oct 2023
FDA Updates Off-Label Communications Guidance
Article
20 Jul 2023
FDA And FTC Guidance Documents Target Direct-To-Consumer Medical Product Promotion
Article
07 Mar 2023
FTC And NAD Remind Industry Of Their Authority Over All Health Product Advertising (Including Rx)
Article
06 Feb 2023
NAD Reminds Industry That The Door Is Open For Competitor Prescription Drug Advertising Challenges
Article
08 Jul 2022
FDA Proposes Rule On Use Of Innovative Technologies And Other Conditions Of Use To Expand Options For Nonprescription Drug Products
Article
07 Jun 2022
FTC Proposed Updates To Endorsement Guides And .com Disclosures Guidance Signal Continued Regulatory Focus On Influencers And Social Media